Danaher Corporation (NYSE: DHR) (the "Company") announced that its President and Chief Executive Officer, Rainer M. Blair, will comment tomorrow on the Company's fourth quarter 2025 performance in a ...

With tariff rules finalized and inventories depleted, there’s light at the end of the tunnel for the medical and scientific ...

Danaher (DHR) is an American global conglomerate with a strong presence in the life sciences and diagnostics industries. It’s an under-the-radar compounder that has consistently grown over the past ...

Through its Danaher Business System, Danaher aims for continuous improvement of its scientific technology portfolio by seeking out attractive markets and then making acquisitions to enter or expand ...

We came across a bullish thesis on Danaher Corporation on Heavy Moat Investments’s Substack. In this article, we will summarize the bulls’ thesis on DHR. Danaher Corporation’s share was trading at ...

We recently published 10 Stocks Leaving Wall Street in the Dust. Danaher Corp. (NYSE:DHR) is one of the best performers on Tuesday. Danaher bounced back by 5.94 percent on Tuesday to close at $220.77 ...

Danaher's biotechnology growth prospects look assured. Guidance for 2026 is merely within the range of current market expectations. 10 stocks we like better than Danaher › Shares in biotechnology, ...

Through its Danaher Business System, Danaher aims for continuous improvement of its scientific technology portfolio by seeking out attractive markets and then making acquisitions to enter or expand ...

Danaher Corporation (NYSE: DHR) (the "Company") announced that its President and Chief Executive Officer, Rainer M. Blair ...